PRESS RELEASES
ALWAYS STAY IN THE KNOW!
Subscribe now to our mailing list to receive the latest press releases.
Jan 6, 2022
iFabric Corp Announces Favourable Ruling on Contract Dispute in China
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), today announced the ruling of the Shanghai International Economic Trade Arbitration Commission (the "Arbitrator") in connection with a contract dispute between its wholly owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and a Chinese N95 mask supplier.
Dec 16, 2021
iFabric Corp Announces Maidenform License Renewal
iFabric Corp. ("iFabric") (TSX:IFA)(OTCQX:IFABF), today announced that its wholly owned subsidiary company, Coconut Grove Pads Inc. ("CGP"), has renewed its license and distribution agreement with HBI IP Holdings Switzerland GmbH ("HBI" and Maidenform LLC ("Maidenform"). The agreement covers the distribution by CGP of intimate apparel accessories and specialty bra solutions which, are marketed under various Maidenform brands.
Oct 13, 2021
iFabric Announces Co-development of Antiviral Air Filter
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"),and Air Quality Enhancement Corporation ("AQECO"), have successfully completed the co-development of a PROTX2® treated, antiviral post air filter, suitable for use in commercial and residential buildings.
Sept 1, 2021
OTC Markets Group Welcomes iFarbic Corp. to OTCQX
NEW YORK, Sept. 1, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced iFabric Corp. (TSX: IFA; OTCQX: IFABF), a company with subsidiaries Intelligent Fabric Technologies (North America) Inc. ('IFTNA') and Coconut Grove Pads Inc. ('Coconut Grove'), has qualified to trade on the OTCQX® Best Market. iFabric Corp. qupgraded to OTCQX from the Pink® market.
Aug 12, 2021
iFabric Corp Reports Results for Its Third Quarter and Nine Months Ended June 30, 2021
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA) (OTC PINK:IFABF), today announced its financial results for its third quarter and nine months ended June 30, 2021. "I am pleased to report that our Intimate Apparel Division returned to profitability in the third quarter and
with both our operating divisions now profitable, we saw a significant turnaround in earnings during the quarter," said Hylton Karon President and CEO of iFabric.
Aug 9, 2021
iFabric Corp. to Present at the SNN Network Summer Virtual Event on Thursday, August 19,2021
iFabric Corp. ("iFabric " or the " Company") (TSX:IFA), a leader in proprietary chemical formulations that render fabrics, foams, plastics, and numerous other surfaces intelligent, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on August 19th, at 11 AM EST. Hylton Karon, President and CEO of iFabric Corp. and Giancarlo Beevis, CEO of the Company's Intelligent Fabric Division, will be hosting the presentation and answering questions from investors.
Jul 28, 2021
iFabric Corp. Announces Exclusive Global License Agreement With Springs Window Fashions for Use of PROTX2®
iFabric Corp. ('iFabric' or the 'Company') (TSX:IFA)(OTC:IFABF), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ('IFTNA'), has signed an exclusive, global license and supply agreement with Springs Window Fashions LLC ("SWF") for its PROTX2® technologies for use in window coverings. Extensive testing conducted by the Company have shown that PROTX2® possesses broad spectrum antibacterial and antiviral properties and by its use can assist in combating healthcare and community acquired bacterial infections, including MRSA, Clostridium Difficile, VRE, Klebsiella Pneumonia, amongst others. In addition, PROTX2® has displayed the proven ability to deactivate viruses, including SARS-CoV-2 (which causes the COVID-19 disease), as well as Norovirus and H1N1.
Jun 23, 2021
Rhino Medical Supply Tapped as Distributor of America Knits-Field to Closet Cotton Medical Scrubs - Featuring iFabric Corp.'s PROTX2®AV technology
The Field to Closet 100% Cotton medical scrub is treated with the latest technology, PROTX2®AV which is a metal free, medical grade anti-viral, anti-bacteria, and anti-odor treatment that kills the virus or bacteria within 10 minutes (or less) of contact. This is the first surgical scrub made from 100% cotton that has been treated with this technology. Lance Brown of Rhino Medical calls the technology a “game changer” for the US medical industry in its fight to prevent another pandemic outbreak. “We are thrilled to partner with Field and Closet to introduce the first OR scrubs powered by PROTX2®AV technology. This is a key step in breaking the chain of infection and provides healthcare professionals with a new line of defense in infection prevention,” adds Mr. Giancarlo Beevis, President and CEO of Intelligent Fabric Technologies, North America.
Jun 1, 2021
iFabric Corp. Provides update on EPA Public Health Claim Registration
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has received an update from the United States Environmental Agency registration ("EPA") for its public health claim registrations. "IFTNA has received new guidance from the EPA agreeing to a request by IFTNA about the public health claims it is seeking. IFTNA has requested that its public health claims be registered in a manner that prevents competitors from leveraging IFTNA's results and registrations in order to shorten their own registration timelines. Under the revised EPA guidance, any competitor will still be required to replicate IFTNA's full test results with respect of the eEcacy of PROTX2 for deactivating the various pathogens mandated by the EPA, which in the opinion of the Company is unlikely.
May 27, 2021
iFabric Corp. Announces EPA Registration of New Technology bioTX
iFabric Corp. ("iFabric" or the "Company") (IFA.TO), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has received a United States Environmental Agency ("EPA") registration for its new metal-free antimicrobial technology, bioTX. "bioTX, represents the culmination of a lengthy period of development and testing of a metal-free antimicrobial and is a worthy addition to the Company's class leading portfolio of anti-microbial, anti-bacterial, anti-viral and odour control solutions. We are constantly looking for ways to add to or improve upon our current line of products," said Giancarlo Beevis, President and CEO of IFTNA.
May 5, 2021
iFabric Corp. Announces Signing of License Agreement with Performance Luxury Brand TUMI to Integrate PROTX2 Technology
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA.TO), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") has entered into a license agreement with Tumi Inc. ("TUMI"). ".......The license with TUMI is non-exclusive and covers the integration of our class leading PROTX2® anti-microbial technologies in select TUMI luggage and backpacks. When you think about all of life's major touch points, home, work, travel, school, and recreation, TUMI products cover all of those categories. Integrating our technologies offers TUMI customers a broad range of cleaner products, that perfectly blend TUMI style with the unique protection of their products," stated Giancarlo Beevis, President and Chief Executive Officer of IFNTA.
Apr 1, 2021
iFabric Corp. Announces Annual General Meeting Voting Results
iFabric Corp. (TSX:IFA) ("iFabric") is pleased to announce that at its annual meeting of shareholders, held virtually on March 31, 2021, shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be reviewed in iFabric's information circular which was filed on www.sedar.com on March 2, 2021. All of the director nominees listed in the information circular were elected/re-elected as directors of iFabric.
Mar 29, 2021
iFabric Corp.: Reminder - Annual and Special General Meeting of Shareholders
iFabric Corp. (TSX:IFA) (the "Company") reminds its shareholders (the "Shareholders") that its annual general meeting (the "Meeting") will be held on March 31, 2021 at 10:30 a.m. (Toronto time), solely by means of remote communication, rather than in person, at the time and for the purposes set forth in the Notice of Meeting available on SEDAR under the Company's profile. Due to the public health impact of COVID-19, and to mitigate risks to the health and safety of our community, Shareholders, employees and other stakeholders, the Company is conducting a virtual meeting of the Shareholders of the Company. Shareholders will not be able to attend the Meeting in person.
Mar 18, 2021
iFabric Corp. Satisfies Escrow Release Condition in Connection with Offering of Subscription Receipts
iFabric Corp.. (TSX::IFA) (the "Company") is pleased to announce that it has satisfied the escrow release condition in respect of its approximately $11,500,000 private placement offering of 2,948,717 subscription receipts ("Subscription Receipts") completed on February 22, 2021 (the "Offering") by obtaining a receipt (the "Receipt") today for the final short form prospectus (the "Prospectus") dated March 18, 2021 filed in the provinces of Ontario, British Columbia, Alberta and Nova Scotia qualifying for distribution 2,948,717 units of the Company (the "Units") issuable upon the automatic conversion of the Subscription Receipts.
Mar 12, 2021
iFabric Corp. Reports Results for Its Second Quarter Ended March 31, 2021
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA), today announced its financial results for its second quarter and six months ended March 31, 2021. "I am pleased to report that the Intelligent Fabric Technology (North America) Inc. Division accomplished growth of over 100% compared to Q2 2020, in what is traditionally the weakest quarter of the year for both divisions. The lingerie division's customer base being traditional retailers, has not yet recovered to pre-pandemic numbers......" said Hylton Karon, President and CEO of iFabric Corp.
Feb 22, 2021
iFabric Corp. Closes $11.5M Private Placement of Subscription Receipts Including Full Exercise of Agents' Option
iFabric Corp. (IFA.TO) (the "Company") announced today that it has closed its previously announced brokered best efforts private placement offering (the "Offering") of subscription receipts (each, a "Subscription Receipt"). On closing of the Offering, the Company issued a total of 2,948,717 Subscription Receipts at a price of $3.90 per Subscription Receipt (the "Issue Price") for gross proceeds of approximately $11,500,000, including the full exercise of the agents’ option granted to the Agents (as defined herein) in connection with the Offering.
Feb 12, 2021
iFabric Engages Independent Trading Group for Market Making Services
iFabric Corp. (the “Company” or “iFabric”) (TSX: IFA) (OTC: IFABF) announced today that it has engaged Independent Trading Group (ITG), Inc. (“ITG”) to provide market-making services on the Toronto Stock Exchange (“TSX”) and other marketplaces, as applicable, in compliance with the policies and guidelines of the TSX and other applicable regulation. The objective is to maintain a reasonable market and improve the liquidity of the Common Shares.
Feb 11, 2021
iFabric Corp. Announces Record Q1 2021 Revenues and Earnings
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA.TO), today announced its results for its first quarter ended December 31, 2020. "I am extremely proud of our first quarter performance which represents a testament to the relevancy of our technologies during this unique and tumultuous time. The capabilities of our class-leading technologies and high-quality apparel programs continue to resonate with our customers and their consumers both in-store and across multiple digital platforms,” said Hylton Karon, President and CEO of iFabric.
Feb 1, 2021
iFabric Corp. Announces Maidenform License Renewal
iFabric Corp. (“iFabric” or the “Company”) (IFA.TO), today announced that its wholly owned subsidiary company, Coconut Grove Pads Inc. ("CGP"), has renewed its license and distribution agreement with MFB International Holdings S.a.r.l., a subsidiary of Hanesbrands Inc. (“Hanes”). The agreement covers the distribution by CGP of intimate apparel accessories and specialty bra solutions which are marketed under Hanes' various Maidenform brands.
Jan 27, 2021
iFabric Corp. Provides Revenue Guidance for Fiscal 2021 First Quarter
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTC: IFABF), today provides revenue guidance for the first quarter of its fiscal 2021. "2021 has started off as a record year for our company. I am extremely pleased that our Intelligent Fabrics division has executed so strongly on the opportunities stemming from the COVID-19 pandemic.” said Hylton Karon, President and CEO of iFabric. “This is evidenced by the Intelligent Fabric division’s significant revenue growth of approximately 170% over the prior quarter ended September 30, 2020 and 270% over Q1 2020.
Jan 20, 2021
iFabric Corp. Withdraws Public Offering of Units and Launches Private Placement of Subscription Receipts
iFabric Corp. (TSX:IFA) (the "Company") announced today that it has made the decision to withdraw its previously announced public offering of units and instead proceed with a private placement of subscription receipts ("Subscription Receipts"), the details of which are set forth below. The decision was made in order to provide the Company with additional time to clear the prospectus associated with the financing and to ensure the financial statements for the Company's interim period ended December 31, 2020 can be included therein.
Jan 19, 2021
iFabric Corp. Announces Overnight Marketed Public Offering
iFabric Corp. (TSX: IFA) (the "Company") today announced that it has filed a preliminary short form prospectus in connection with an overnight marketed public offering (the "Offering") of units of the Company (the "Units"). The size of the Offering will be determined in the context of the market. Each Unit will be offered at $3.90 and consist of one common share (a "Common Share") of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant").
Dec 24, 2020
iFabric Corp. Fourth Quarter and Annual Revenue an Earning for its Financial Year Ended September 30,2020
IFabric Corp. (“iFabric” or the “Company”) (IFA.TO), today announced its results for its 4th quarter and fiscal year ended September 30, 2020. “2020 has been a transitional year for iFabric Corp. The Covid-19 pandemic brought both opportunities and challenges for the Company,” said Hylton Karon, President/CEO of iFabric Corp.
Oct 26, 2020
iFabric Corp. Provides A Corporate Update
iFabric Corp. (“iFabric” or the "Company") (TSX: IFA), is pleased to provide an update on various aspects of the Company's operations. “In light of the difficult business environment of the past 8 months and the significant challenges and opportunities created by the Covid-19 pandemic, management of iFabric Corp felt it would be prudent to provide an update to shareholders on the progress we have made and other issues we have encountered in 2020” said Hylton Karon, President/CEO of iFabric Corp.
Sept 1, 2020
iFabric Corp. Press Release Announces New Covid-19 Laundry Additive and Donates Initial Production to Medical Facility in South Africa
iFabric Corp. (“iFabric”) (TSX: IFA, OTC: IFABF), today announces that its Intelligent Fabric Technologies Division (“IFTNA”) has donated the initial production of its recently developed, proprietary, patent-pending, AVguard anti-viral laundry additive, to The Village Medical Centre in Johannesburg, South Africa.
Jun 23, 2020
iFabric Corp. Announces Further Test Results for Its Antiviral Fabric Treatment
iFabric Corp. (“iFabric”) (TSX: IFA), today provides details of its test results about the efficacy of PROTX2 treated fabrics for inactivating an additional Human Coronavirus (229E). IFabric advises that efficacy testing of PROTX2 treated fabric against this additional Human Coronavirus, type 229E, was carried out by an internationally recognized, independent laboratory in the United States, to establish its ability to inactivate the virus at time points of 10 minutes and 1 hour.
May 11, 2020
IFabric Corp. Announces Antiviral and Antibacterial Textile Treatment is Effective Against Covid-19
iFabric Corp. (“iFabric”) (TSX: IFA), today provides details of its test results about the efficacy of PROTX2 treated fabrics for inactivating the SARS-CoV-2 virus, which is the cause of COVID-19 disease. iFabric advises that efficacy testing of PROTX2 treated fabric against the SARS-CoV-2 virus was carried out by an internationally recognized, independent laboratory to establish its ability to inactivate the virus at time points of 10 minutes, 1 hour, 6 hours, and 24 hours, respectively.
Apr 2, 2020
iFabric Corp. Provides Update on Covid-19 Efficacy Testing
iFabric Corp. (“iFabric”) (TSX: IFA), today provided the following update with regard to efficacy testing of PROTX2 treated fabrics against COVID-19: "I am pleased to announce that efficacy testing of fabrics treated with the anti-viral variant of our PROTX2 formulation will commence shortly” said Hylton Karon, President and CEO of iFabric. “Our testing will be conducted at a top South Korean laboratory, as we were unable to locate any laboratories in North America that currently have availability of the necessary cultures, despite the current pandemic. We would anticipate receiving the initial test results within a period of a few weeks,” continued Mr. Karon.
Apr 1, 2020
iFabric Corp. Announces Board of Director Changes
iFabric Corp. (“iFabric”) (TSX: IFA), today announced the following changes to its Board of Directors: Dr. Mark Cochran, a Board member since May 2015, has been appointed Board Chair in the place of Dr Jeff Coyne. Dr. Cochran currently serves as Executive Director at Johns Hopkins Healthcare Solutions, an operating division of Johns Hopkins Medicine/HealthCare. His professional experience spans the spectrum of the global health care value chain, including drug discovery, development, research and management, and venture capital initiatives.